News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
News
Drug Development
Boehringer Ingelheim Release: New Hope For Hepatitis C Victims
October 19, 2005
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
A new drug that prevents a contagious virus from duplicating in the body could be a new weapon against hepatitis C, a disease that could kill more people than AIDS, scientists said on Sunday.
Twitter
LinkedIn
Facebook
Email
Print
Clinical research
Phase I
Europe
Boehringer Ingelheim Pharmaceuticals, Inc.
MORE ON THIS TOPIC
Earnings
Merck Cuts $3B to Support Aggressive Launch Schedule, Late-Stage R&D
July 29, 2025
·
3 min read
·
Annalee Armstrong
Alzheimer’s disease
Roche’s Next-Gen Alzheimer’s Antibody Clears or Reduces Amyloid Plaques in Seven Months
July 28, 2025
·
2 min read
·
Dan Samorodnitsky
Schizophrenia
Atai-Partnered Schizophrenia Drug Flunks Mid-Stage Trial
July 28, 2025
·
2 min read
·
Tristan Manalac
Collaboration
Eli Lilly Commits $856M in Biobucks to Gate Bioscience for New Class of Medicines
July 25, 2025
·
1 min read
·
Dan Samorodnitsky